Abstract
RAS mutations (HRAS, NRAS, and KRAS) are among the most common oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
